Insider · CIK 0001882764
Hohl Benjamin
cfoofficer
Files at ELVN (Enliven Therapeutics, Inc.). First filing Oct 22, 2024, latest Dec 31, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $428k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 17Weak | sell10b5-1 | ELVN Enliven Therapeutics, Inc. | $94k | 4,250 | -127% | - | |
| 18Weak | sell10b5-1 | ELVN Enliven Therapeutics, Inc. | $131k | 5,250 | -100% | - | |
| 34Weak | sell 610b5-1 | ELVN Enliven Therapeutics, Inc. | $178k | 6,250 | -100% | - | |
| 22Weak | sell 610b5-1 | ELVN Enliven Therapeutics, Inc. | $24k | 814 | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 27, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,350 | $2.48 | $8,308 | 3,350 | Dec 31, 2024 |
| Dec 27, 2024 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,350 | $22.15 | $74k | 0 | Dec 31, 2024 |
| Dec 30, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +900 | $2.48 | $2,232 | 900 | Dec 31, 2024 |
| Dec 30, 2024 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -900 | $22.51 | $20k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,350 | $0.00 | $0 | 165,206 | Dec 31, 2024 |
| Dec 30, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -900 | $0.00 | $0 | 164,306 | Dec 31, 2024 |
| Nov 27, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,250 | $2.48 | $13k | 5,250 | Dec 2, 2024 |
| Nov 27, 2024 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,250 | $24.78 | $105k | 1,000 | Dec 2, 2024 |
| Nov 27, 2024 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $25.38 | $25k | 0 | Dec 2, 2024 |
| Nov 27, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -5,250 | $0.00 | $0 | 168,556 | Dec 2, 2024 |
| Oct 28, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +6,250 | $2.48 | $16k | 6,250 | Oct 30, 2024 |
| Oct 28, 2024 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,600 | $28.49 | $160k | 650 | Oct 30, 2024 |
| Oct 28, 2024 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -650 | $29.11 | $19k | 0 | Oct 30, 2024 |
| Oct 28, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -6,250 | $0.00 | $0 | 173,806 | Oct 30, 2024 |
| Oct 18, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +814 | $2.48 | $2,019 | 814 | Oct 22, 2024 |
| Oct 18, 2024 | ELVN Enliven Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -814 | $30.00 | $24k | 0 | Oct 22, 2024 |
| Oct 18, 2024 | ELVN Enliven Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -814 | $0.00 | $0 | 180,056 | Oct 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.